dpp 4 inhibitor and glp 1 agonist Role of Dipeptidyl Peptidase Inhibitors in Antidiabetic Treatment DPP4 Inhibitors vs GLP-1 Agonists
Description
That way, you know what counts, what resets, and what kind of play correlates with realistic outcomes
For RFS, the survival probabilities at five and 10 years were 95% and 90.9% with GLP-1RAs and 93.8% and 89.9% with SGLT2 inhibitors, respectively
Nauck M, Frid A, Hermansen K, et al, for LEAD-2 Metformin Study Group
They copy the action of a natural hormone in your body called GLP-1 (glucagon-like peptide-1), which is released after you eat
doi: 10.1164/rccm.201903-0692OC
